4(3H)-Quinazolinone, 2-(4-chlorophenyl)-7-methoxy-3-methyl-

DK1 is a potent modulator of estrogen related receptor. DK1 has an ability in reducing blood glucose, and impacts the activity of ERRα receptor. DK1 has the potential for the research of diabetes[1].

DK1 is a potent modulator of estrogen related receptor. DK1 has an ability in reducing blood glucose, and impacts the activity of ERRα receptor. DK1 has the potential for the research of diabetes[1].

[1]. Fuxing Li, et al. Computational investigation of the interaction mechanism between the estrogen related receptor α and its agonists. [2]. Fuxing Li, et al. Computational investigation of the interaction mechanism between the estrogen related receptor α and its agonists.